Документ применяется с 1 января 2025 года. До этого срока действует в предыдущей редакции.

Список литературы

1. Brown R., Gagnon R., Delisle M.-F., MATERNAL FETAL MEDICINE COMMITTEE. Cervical insufficiency and cervical cerclage. J Obstet Gynaecol Can. 2013; 35(12): 1115 - 27.

2. Kagan K.O. S.J. How to measure cervical length. Ultrasound Obstet Gynecol. 2015; 45(3): 358 - 362.

3. Lee S.E., Romero R., Park C.-W., Jun J.K., Yoon B.H. The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency. Am J Obstet Gynecol. 2008; 198(6): 633. e1 - 8.

4. Romero R., Chaiworapongsa T., Meyyazhagan A., Jung E., Yoon B.H., Kmak D., et al. Treatment of cervical insufficiency and/or a short cervix with antimicrobial agents can restore cervical length and lead to pregnancy prolongation and term delivery. J Matern Neonatal Med. 2024; 37(1).

5. Chan Y.Y., Jayaprakasan K., Tan A., Thornton J.G., Coomarasamy A., Raine-Fenning N.J. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011; 38(4): 371 - 82.

6. Johnstone F.D., Beard R.J., Boyd I.E., McCarthy T.G. Cervical diameter after suction termination of pregnancy. Br Med J. 1976; 1(6001): 68 - 9.

7. Kyrgiou M., Arbyn M., Martin-Hirsch P., Paraskevaidis E. Increased risk of preterm birth after treatment for CIN. BMJ. 2012; 345: e5847.

8. Anum E.A., Springel E.H., Shriver M.D., Strauss J.F. Genetic contributions to disparities in preterm birth. Pediatr Res. 2009; 65(1): 1 - 9.

9. Warren J.E., Silver R.M., Dalton J., Nelson L.T., Branch D.W., Porter T.F. Collagen 1Alpha1 and transforming growth factor-beta polymorphisms in women with cervical insufficiency. Obstet Gynecol. 2007; 110(3): 619 - 24.

10. De Vos M., Nuytinck L., Verellen C., De Paepe A. Preterm premature rupture of membranes in a patient with the hypermobility type of the Ehlers-Danlos syndrome. A case report. Fetal Diagn Ther. 14(4): 244 - 7.

11. Warren J.E., Silver R.M. Genetics of the cervix in relation to preterm birth. Semin Perinatol. 2009; 33(5): 308 - 11.

12. Miller R., Smiley R., Thom E.A., Grobman W.A., Iams J.D., Mercer B.M., et al. The association of beta-2 adrenoceptor genotype with short-cervix mediated preterm birth: a case-control study. BJOG. 2015; 122(10): 1387 - 94.

13. Gernand A.D., Schulze K.J., Stewart C.P., West K.P., Christian P. Micronutrient deficiencies in pregnancy worldwide: health effects and prevention. Nat Rev Endocrinol. 2016; 12(5): 274 - 89.

14. Yamamoto T., Nomiyama M., Oshima Y., Ono T., Kozuma Y., Nakura Y., et al. Prenatal exposure to intra-amniotic infection with Ureaplasma species increases the prevalence of bronchopulmonary dysplasia. J Matern Neonatal Med. 2024; 37(1).

15. Berger R., Abele H., Bahlmann F., Doubek K., 00000002.wmz U., Fluhr H., et al. Prevention and Therapy of Preterm Birth. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/025, September 2022) - Part 1 with Recommendations on the Epidemiology, Etiology, Prediction, Primary and Secondary Prevention of Preterm B. Geburtshilfe Frauenheilkd. 2023; 83(05): 547 - 68.

16. Thakur M., Mahajan K. Cervical Incompetence. StatPearls. 2021.

17. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 142: Cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014; 123(2 Pt 1): 372 - 9.

18. Клинические рекомендации "Нормальная беременность" 2023 г. https://cr.minzdrav.gov.ru/recomend/288_2.

19. Савельева Г.М., Сухих Г.Т. Серов В.Н. Акушерство. Национальное руководство. 2-е издание. 2018. 1735 стр.

20. Palacio M., 00000003.wmz M., Berger R., Larios C.L., Marcellin L. Meta-analysis of studies on biochemical marker tests for the diagnosis of premature rupture of membranes: comparison of performance indexes. BMC Pregnancy Childbirth. 2014; 14: 183.

21. Alexander J.M., Mercer B.M., Miodovnik M., Thurnau G.R., Goldenberg R.L., Das A.F., et al. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol. 2000; 183(4): 1003 - 7.

22. Judd W.J., Luban N.L., Ness P.M., Silberstein L.E., Stroup M., Widmann F.K. Prenatal and perinatal immunohematology: recommendations for serologic management of the fetus, newborn infant, and obstetric patient. Transfusion. 1990; 30(2): 175 - 83.

23. McBain R.D., Crowther C.A., Middleton P. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation. Cochrane database Syst Rev. 2015; (9): CD000020.

24. Клинические рекомендации "Резус-изоиммунизация. Гемолитическая болезнь плода" 2020 г. https://cr.minzdrav.gov.ru/recomend/596_2.

25. Bond D.M., Middleton P., Levett K.M., van der Ham D.P., Crowther C.A., Buchanan S.L., et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome. Cochrane database Syst Rev. 2017; 3: CD004735.

26. 00000004.wmz Sabogal C.P., Fonseca J., 00000005.wmz H.A. Validation of diagnostic tests for histologic chorioamnionitis: Systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018; 228: 13 - 26.

27. Ahmadi M.H., Mirsalehian A., Bahador A. Association of Chlamydia trachomatis with infertility and clinical manifestations: a systematic review and meta-analysis of case-control studies. Infect Dis (London, England). 2016; 48(7): 517 - 23.

28. Lis R., Rowhani-Rahbar A., Manhart L.E. Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis. 2015; 61(3): 418 - 26.

29. Chemaitelly H., Majed A., Abu-Hijleh F., Blondeel K., Matsaseng T.C., Kiarie J., et al. Global epidemiology of Neisseria gonorrhoeae in infertile populations: systematic review, meta-analysis and metaregression. Sex Transm Infect. 2021; 97(2): 157 - 69.

30. Wiringa A.E., Ness R.B., Darville T., Beigi R.H., Haggerty C.L. Trichomonas vaginalis, endometritis and sequelae among women with clinically suspected pelvic inflammatory disease. Sex Transm Infect. 2020; 96(6): 436 - 8.

31. Ladfors L., Mattssoni 00000006.wmz., Eriksson M., Fall O. Is a speculum examination sufficient for excluding the diagnosis of ruptured fetal membranes? Acta Obstet Gynecol Scand. 1997; 76(8): 739 - 42.

32. Leitich H., Brunbauer M., Kaider A., Egarter C., Husslein P. Cervical length and dilatation of the internal cervical os detected by vaginal ultrasonography as markers for preterm delivery: A systematic review. Am J Obstet Gynecol. 1999; 181(6): 1465 - 72.

33. Ting H.-S., Chin P.-S., Yeo G.S.H., Kwek K. Comparison of bedside test kits for prediction of preterm delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore. 2007; 36(6): 399 - 402.

34. Alfirevic Z., Allen-Coward H., Molina F., Vinuesa C.P., Nicolaides K. Targeted therapy for threatened preterm labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol. 2007; 29(1): 47 - 50.

35. Ehsanipoor R.M., Swank M.L., Jwa S.C., Wing D.A., Tarabulsi G., Blakemore K.J. Placental 00000007.wmz in Vaginal Secretions of Women with Evidence of Preterm Labor. Am J Perinatol. 2016; 33(2): 208 - 13.

36. Corabian P. The ACTIMTM PARTUS versus THE TLIIQ 00000008.wmz SYSTEM as rapid response tests to aid in diagnosing preterm labour in symptomatic women. In: Institute of Health Economics, Canada. 2008.

37. Berghella V., Palacio M., Ness A., Alfirevic Z., Nicolaides K.H., Saccone G. Cervical length screening for prevention of preterm birth in singleton pregnancy with threatened preterm labor: systematic review and meta-analysis of randomized controlled trials using individual patient-level data. Ultrasound Obstet Gynecol. 2017; 49(3): 322 - 9.

38. Newman R.B., Goldenberg R.L., Iams J.D., Meis P.J., Mercer B.M., Moawad A.H., et al. Preterm prediction study: comparison of the cervical score and Bishop score for prediction of spontaneous preterm delivery. Obstet Gynecol. 2008; 112(3): 508 - 15.

39. Einerson B.D., Grobman W.A., Miller E.S. Cost-effectiveness of risk-based screening for cervical length to prevent preterm birth. Am J Obstet Gynecol. 2016; 215(1): 100. e1 - 7.

40. Norman J.E., Marlow N., Messow C.-M., Shennan A., Bennett P.R., Thornton S., et al. Does progesterone prophylaxis to prevent preterm labour improve outcome? A randomised double-blind placebo-controlled trial (OPPTIMUM). Health Technol Assess. 2018; 22(35): 1 - 304.

41. Medley N., Poljak B., Mammarella S., Alfirevic Z. Clinical guidelines for prevention and management of preterm birth: a systematic review. BJOG. 2018; 125(11): 1361 - 9.

42. Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org, McIntosh J., Feltovich H., Berghella V., Manuck T. The role of routine cervical length screening in selected high-and low-risk women for preterm birth prevention. Am J Obstet Gynecol. 2016; 215(3): B2 - 7.

43. Abdel-Aleem H., Shaaban O.M., Abdel-Aleem M.A. Cervical pessary for preventing preterm birth. Cochrane database Syst Rev. 2013; (5): CD007873.

44. 00000009.wmz F.R., Chedraui P., 00000010.wmz G.R., 00000011.wmz S.J. Effectiveness of the cervical pessary for the prevention of preterm birth in singleton pregnancies with a short cervix: a meta-analysis of randomized trials. Arch Gynecol Obstet. 2019; 299(5): 1215 - 31.

45. Kyvernitakis I., Baschat A.A., Malan M., Rath W., Berger R., Henrich W., et al. Cervical pessary to prevent preterm birth and poor neonatal outcome: An integrity meta-analysis of randomized controlled trials focusing on adherence to the European Medical Device Regulation. Int J Gynecol Obstet. 2024; 165(2): 607 - 20.

46. Roman A.R., Da Silva Costa F., Araujo 00000012.wmz E., Sheehan P.M. Rescue Adjuvant Vaginal Progesterone May Improve Outcomes in Cervical Cerclage Failure. Geburtshilfe Frauenheilkd. 2018; 78(8): 785 - 90.

47. Cruz-Melguizo S., San-Frutos L., 00000013.wmz C., 00000014.wmz B., Adiego-Burgos B., Campillos-Maza J.M., et al. Cervical Pessary Compared With Vaginal Progesterone for Preventing Early Preterm Birth: A Randomized Controlled Trial. Obstet Gynecol. 2018; 132(4): 907 - 15.

48. Goya M., de la Calle M., Pratcorona L., Merced C., 00000015.wmz C., 00000016.wmz B., et al. Cervical pessary to prevent preterm birth in women with twin gestation and sonographic short cervix: a multicenter randomized controlled trial (PECEP-Twins). Am J Obstet Gynecol. 2016; 214(2): 145 - 52.

49. Goya M., Cabero L. Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial. Am J Obstet Gynecol. 2016; 214(2): 301 - 2.

50. Thangatorai R., Lim F.C., Nalliah S. Cervical pessary in the prevention of preterm births in multiple pregnancies with a short cervix: PRISMA compliant systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2018; 31(12): 1638 - 45.

51. Fox N.S., Gupta S., Lam-Rachlin J., Rebarber A., Klauser C.K., Saltzman D.H. Cervical Pessary and Vaginal Progesterone in Twin Pregnancies With a Short Cervix. Obstet Gynecol. 2016; 127(4): 625 - 30.

52. Koullali B., Westervelt A.R., Myers K.M., House M.D. Prevention of preterm birth: Novel interventions for the cervix. Semin Perinatol. 2017; 41(8): 505 - 10.

53. Zheng L., Dong J., Dai Y., Zhang Y., Shi L., Wei M., et al. Cervical pessaries for the prevention of preterm birth: a systematic review and meta-analysis. J Matern Neonatal Med. 2019; 32(10): 1654 - 63.

54. Hassan S.S., Romero R., Vidyadhari D., Fusey S., Baxter J.K., Khandelwal M., et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol. 2011; 38(1): 18 - 31.

55. Romero R., Nicolaides K., Conde-Agudelo A., Tabor A., O'Brien J.M., Cetingoz E., et al. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol. 2012; 206(2): 124. e1 - 19.

56. Romero R., Nicolaides K.H., Conde-Agudelo A., O'Brien J.M., Cetingoz E., Da Fonseca E., et al. Vaginal progesterone decreases preterm birth <= 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol. 2016; 48(3): 308 - 17.

57. Romero R., Conde-Agudelo A., Da Fonseca E., O'Brien J.M., Cetingoz E., Creasy G.W., et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018; 218(2): 161 - 80.

58. Conde-Agudelo A., Romero R., Da Fonseca E., O'Brien J.M., Cetingoz E., Creasy G.W., et al. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis. Am J Obstet Gynecol. 2018; 219(1): 10 - 25.

59. Kyvernitakis I., Maul H., Bahlmann F. Controversies about the Secondary Prevention of Spontaneous Preterm Birth. Geburtshilfe Frauenheilkd. 2018; 78(06): 585 - 95.

60. Norman J.E., Mackenzie F., Owen P., Mactier H., Hanretty K., Cooper S., et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet (London, England). 2009; 373(9680): 2034 - 40.

61. Norman J.E., Marlow N., Messow C.-M., Shennan A., Bennett P.R., Thornton S., et al. Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): a multicentre, randomised, double-blind trial. Lancet. 2016; 387(10033): 2106 - 16.

62. Ashoush S., El-Kady O., Al-Hawwary G., Othman A. The value of oral micronized progesterone in the prevention of recurrent spontaneous preterm birth: a randomized controlled trial. Acta Obstet Gynecol Scand. 2017; 96(12): 1460 - 6.

63. Dodd J.M., Grivell R.M., OBrien C.M., Dowswell T., Deussen A.R. Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy. Cochrane Database Syst Rev. 2017;.

64. Stewart L.A., Simmonds M., Duley L., Llewellyn A., Sharif S., Walker R.A., et al. Evaluating Progestogens for Preventing Preterm birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. Lancet. 2021; 397(10280): 1183 - 94.

65. Crowther C.A., Ashwood P., McPhee A.J., Flenady V., Tran T., Dodd J.M., et al. Vaginal progesterone pessaries for pregnant women with a previous preterm birth to prevent neonatal respiratory distress syndrome (the PROGRESS Study): A multicentre, randomised, placebo-controlled trial. PLoS Med. 2017; 14(9): e1002390.

66. Campbell S. Universal cervical-length screening and vaginal progesterone prevents early preterm births, reduces neonatal morbidity and is cost saving: doing nothing is no longer an option. Ultrasound Obstet Gynecol. 2011; 38(1): 1 - 9.

67. Dodd J.M., Jones L., Flenady V., Cincotta R., Crowther C.A. Prenatal administration of progesterone for preventing preterm birth in women considered to be at risk of preterm birth. Cochrane database Syst Rev. 2013; (7): CD0049(7): CD004947.

68. Kumar A., Begum N., Prasad S., Aggarwal S., Sharma S. Oral dydrogesterone treatment during early pregnancy to prevent recurrent pregnancy loss and its role in modulation of cytokine production: a double-blind, randomized, parallel, placebo-controlled trial. Fertil Steril. 2014; 102(5): 1357 - 1363. e3.

69. Yasuda K., Sumi G.-I., Murata H., Kida N., Kido T., Okada H. The steroid hormone dydrogesterone inhibits myometrial contraction independently of the progesterone/progesterone receptor pathway. Life Sci. 2018; 207: 508 - 15.

70. Miller E.S., Grobman W.A., Fonseca L., Robinson B.K. Indomethacin and antibiotics in examination-indicated cerclage: a randomized controlled trial. Obstet Gynecol. 2014; 123(6): 1311 - 6.

71. Owen J., Hankins G., Iams J.D., Berghella V., Sheffield J.S., Perez-Delboy A., et al. Multicenter randomized trial of cerclage for preterm birth prevention in high-risk women with shortened midtrimester cervical length. Am J Obstet Gynecol. 2009; 201(4): 375. e1 - 8.

72. Практическое руководство по антиинфекционной химиотерапии/Под ред. Л.С. Страчунского, Ю.Б. Белоусова, С.Н. Козлова. - Смоленск: МАКМАХ, 2007. - 464 с.

73. Althuisius S.M., Dekker G.A., Hummel P., Bekedam D.J., van Geijn H.P. Final results of the Cervical Incompetence Prevention Randomized Cerclage Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am J Obstet Gynecol. 2001; 185(5): 1106 - 12.

74. Ciavattini A., Delli Carpini G., Boscarato V., Febi T., Di Giuseppe J., Landi B. Effectiveness of emergency cerclage in cervical insufficiency. J Matern Fetal Neonatal Med. 2016; 29(13): 2088 - 92.

75. Тетруашвили Н.К., Агаджанова А.А. М.А.К. Коррекция истмико-цервикальной недостаточности при пролабировании плодного пузыря: возможности терапии. Акушерство и гинекология. 2015; (9).

76. Программа СКАТ (Стратегия Контроля Антимикробной Терапии) при оказании стационарной медицинской помощи: Российские клинические рекомендации/Под ред. С.В. Яковлева, Н.И. Брико, С.В. Сидоренко, Д.Н. Проценко. - М.: Издательство "Перо", 2018. - 156 с.

77. Shennan A., Chandiramani M., Bennett P., David A.L., Girling J., Ridout A., et al. MAVRIC: a multicenter randomized controlled trial of transabdominal vs transvaginal cervical cerclage. Am J Obstet Gynecol. 2020; 222(3): 261. e1 - 261. e9.

78. Ishioka S., Kim M., Mizugaki Y., Kon S., Isoyama K., Mizuuchi M., et al. Transabdominal cerclage (TAC) for patients with ultra-short uterine cervix after uterine cervix surgery and its impact on pregnancy. J Obstet Gynaecol Res. 2018; 44(1): 61 - 6.

79. Gesson-Paute A., Berrebi A., Parant O. [Transabdominal cervico-isthmic cerclage in the management of cervical incompetence in high risk women]. J Gynecol Obstet Biol Reprod (Paris). 2007; 36(1): 30 - 5.

80. El-Nashar S.A., Paraiso M.F., Rodewald K., Muir T., Abdelhafez F., Lazebnik N., et al. Laparoscopic cervicoisthmic cerclage: technique and systematic review of the literature. Gynecol Obstet Invest. 2013; 75(1): 1 - 8.

81. Shin J.E., Kim M.J., Kim G.W., Lee D.W., Lee M.K., Kim S.J. Laparoscopic transabdominal cervical cerclage: Case report of a woman without exocervix at 11 weeks gestation. Obstet Gynecol Sci. 2014; 57(3): 232 - 5.

82. Clark N. V, Einarsson J.I. Laparoscopic abdominal cerclage: a highly effective option for refractory cervical insufficiency. Fertil Steril. 2020; 113(4): 717 - 22.

83. Umstad M.P., Quinn M.A., Ades A. Transabdominal cervical cerclage. Aust N Z J Obstet Gynaecol. 2010; 50(5): 460 - 4.

84. Vousden N.J., Carter J., Seed P.T., Shennan A.H. What is the impact of preconception abdominal cerclage on fertility: evidence from a randomized controlled trial. Acta Obstet Gynecol Scand. 2017; 96(5): 543 - 6.

85. Shennan A., Story L., Jacobsson B., Grobman W.A. FIGO good practice recommendations on cervical cerclage for prevention of preterm birth. Int J Gynecol Obstet. 2021; 155(1): 19 - 22.

86. Marchand G., Taher Masoud A., Azadi A., Govindan M., Ware K., King A., et al. Efficacy of laparoscopic and trans-abdominal cerclage (TAC) in patients with cervical insufficiency: A systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2022; 270: 111 - 25.

87. Alfirevic Z., Stampalija T., Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane database Syst Rev. 2017; 6: CD008991.

88. Ehsanipoor R.M., Seligman N.S., Saccone G., Szymanski L.M., Wissinger C., Werner E.F., et al. Physical Examination-Indicated Cerclage: A Systematic Review and Meta-analysis. Obstet Gynecol. 2015; 126(1): 125 - 35.

89. Chatzakis C., Efthymiou A., Sotiriadis A., Makrydimas G. Emergency cerclage in singleton pregnancies with painless cervical dilatation: A meta-analysis. Acta Obstet Gynecol Scand. 2020; 99(11): 1444 - 57.

90. NICE Guidance, Preterm labour and birth, 2016.

91. Preterm labour and birth. NICE guideline NG25. London: National Institute for Health and Care Excellence (UK). 2015.

92. Rafael T.J., Berghella V. A.Z. Cervical stitch for preventing preterm birth in women with a multiple pregnancy. Cochrane Libr. 2014; 9.

93. Saccone G., Rust O., Althuisius S., Roman A., Berghella V. Cerclage for short cervix in twin pregnancies: systematic review and meta-analysis of randomized trials using individual patient-level data. Acta Obstet Gynecol Scand. 2015; 94(4): 352 - 8.

94. Li C., Shen J., Hua K. Cerclage for women with twin pregnancies: a systematic review and metaanalysis. Am J Obstet Gynecol. 2019; 220(6): 543 - 557. e1.

95. Gupta M., Emary K., Impey L. Emergency cervical cerclage: predictors of success. J Matern Fetal Neonatal Med. 2010; 23(7): 670 - 4.

96. Roberts D., Brown J., Medley N., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database Syst Rev. 2017; 3: CD004454.

97. Magann E.F., Haram K., Ounpraseuth S., Mortensen J.H., Spencer H.J., Morrison J.C. Use of antenatal corticosteroids in special circumstances: a comprehensive review. Acta Obstet Gynecol Scand. 2017; 96(4): 395 - 409.

98. Melamed N., Shah J., Yoon E.W., Pelausa E., Lee S.K., Shah P.S., et al. The role of antenatal corticosteroids in twin pregnancies complicated by preterm birth. Am J Obstet Gynecol. 2016; 215(4): 482. e1 - 9.

99. Norman M., Piedvache A., 00000017.wmz K., Huusom L.D., Bonamy A.-K.E., Howell E.A., et al. Association of Short Antenatal Corticosteroid Administration-to-Birth Intervals With Survival and Morbidity Among Very Preterm Infants: Results From the EPICE Cohort. JAMA Pediatr. 2017; 171(7): 678 - 86.

100. ACOG Committee Opinion No. 677: antenatal corticosteroid therapy for fetal maturation, 2017.

101. Been J. V, Degraeuwe P.L., Kramer B.W., Zimmermann L.J.I. Antenatal steroids and neonatal outcome after chorioamnionitis: a meta-analysis. BJOG. 2011; 118(2): 113 - 22.

102. Amiya R.M., Mlunde L.B., Ota E., Swa T., Oladapo O.T., Mori R. Antenatal Corticosteroids for Reducing Adverse Maternal and Child Outcomes in Special Populations of Women at Risk of Imminent Preterm Birth: A Systematic Review and Meta-Analysis. PLoS One. 2016; 11(2): e0147604.

103. ACOG, Practice Bulletin No. 171: Management of Preterm Labor, 2016.

104. King J., Flenady V., Cole S., Thornton S. Cyclo-oxygenase (COX) inhibitors for treating preterm labour. Cochrane database Syst Rev. 2005; 18; (2): CD0(2): CD001992.

105. Клинические рекомендации "Преждевременные роды" 2020 г. https://cr.minzdrav.gov.ru/recomend/331_1.

106. Preterm Labor and Birth Management: Recommendations from the European Association of Perinatal Medicine, 2017.

107. American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for perinatal care. 8th ed. Elk Grove Village, IL; Washington, DC; 2017.

108. Aaronson J., Goodman S. Obstetric anesthesia: not just for cesareans and labor. Semin Perinatol. 2014; 38(6): 378 - 85.

109. Wortman M., Carroll K. Office-Based Gynecologic Surgery (OBGS): Past, Present, and Future: Part I. Surg Technol Int. 2019; 35: 173 - 84.

110. Chestnut D.H., Wong C.A., Tsen L.C., Kee W.D.N., Beilin Y., Mhyre J. Chestnut's Obstetric Anesthesia: Principles and Practice, 5th Edition. Elsevier Science; 2014. 1304 p.

111. Rahman A. Shnider and Levinson's Anesthesia for Obstetrics, Fifth Edition. Anesthesiology. 2015; 122(1): 223.

112. L. Fleisher, Wiener-Kronish J. Miller's Anesthesia, 9th Edition. Anesthesiology. 2019;.

113. Yoon H.J., Hong J.-Y., Kim S.M. The effect of anesthetic method for prophylactic cervical cerclage on plasma oxytocin: a randomized trial. Int J Obstet Anesth. 2008; 17(1): 26 - 30.

114. Ioscovich A., Popov A., Gimelfarb Y., Gozal Y., Orbach-Zinger S., Shapiro J., et al. Anesthetic management of prophylactic cervical cerclage: a retrospective multicenter cohort study. Arch Gynecol Obstet. 2015; 291(3): 509 - 12.

115. Wang Y.-Y., Duan H., Zhang X.-N., Wang S., Gao L. A Novel Cerclage Insertion: Modified Laparoscopic Transabdominal Cervical Cerclage with Transvaginal Removing (MLTCC-TR). J Minim Invasive Gynecol. 2019;.

116. Farber M.K., Bateman B.T. Phenylephrine Infusion: Driving a Wedge in Our Practice of Left Uterine Displacement? Anesthesiology. 2017; 127(2): 212 - 4.

117. Guzman E.R., Pisatowski D.M., Vintzileos A.M., Benito C.W., Hanley M.L., Ananth C. V. A comparison of ultrasonographically detected cervical changes in response to transfundal pressure, coughing, and standing in predicting cervical incompetence. Am J Obstet Gynecol. 1997; 177(3): 660 - 5.

118. Сидельникова В.М. С.Г.Т. Невынашивание беременности: руководство для практикующих врачей. Москва: ООО "Медицинское информационное агентство"; 2011.

119. O'Brien D.P., Murphy J.F. The Shirodkar stitch. Lancet (London, England). 1977; 2(8043): 873 - 4.

120. Odibo A.O., Berghella V., To M.S., Rust O.A., Althuisius S.M., Nicolaides K.H. Shirodkar versus McDonald cerclage for the prevention of preterm birth in women with short cervical length. Am J Perinatol. 2007; 24(1): 55 - 60.

121. Lazar P., Gueguen S., Dreyfus J., Renaud R., Pontonnier G., Papiernik E. Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. Br J Obstet Gynaecol. 1984; 91(8): 731 - 5.

122. Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists multicentre randomised trial of cervical cerclage. MRC/RCOG Working Party on Cervical Cerclage. Br J Obstet Gynaecol. 1993; 100(6): 516 - 23.

123. RUSH R.W., ISAACS S., McPHERSON K., JONES L., CHALMERS I., GRANT A. A randomized controlled trial of cervical cerclage in women at high risk of spontaneous preterm delivery. BJOG An Int J Obstet Gynaecol. 1984; 91(8): 724 - 30.

124. Giraldo-Isaza M.A., Berghella V. Cervical cerclage and preterm PROM. Clin Obstet Gynecol. 2011; 54(2): 313 - 20.

125. Trochez-Martinez R.D., Smith P., Lamont R.F. Use of C-reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review. BJOG. 2007; 114(7): 796 - 801.

126. Banicevic A.C., Popovic M., Ceric A. Cervical length measured by transvaginal ultrasonography and cervicovaginal infection as predictor of preterm birth risk. Acta Inform Med. 2014; 22(2): 128 - 32.